Arcutis Gains FDA Approval for ZORYVE Cream in Children
Westlake Village, California, United States – March 10, 2026 Arcutis Biotherapeutics has announced that the U.S. Food and Drug...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Westlake Village, California, United States – March 10, 2026 Arcutis Biotherapeutics has announced that the U.S. Food and Drug...
SAN DIEGO, California | December 24, 2025 — Dermata Therapeutics, a science-driven dermatology-focused pharmaceutical company, announced a private placement...
